Table: Taiko Pharmaceutical -2019/20 parent results

Taiko Pharmaceutical

12/05/2020 07:00

May 12 (Reuters)- 
          Taiko Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended      9 months to     NEXT     
                Mar 31, 2020    Mar 31, 2019     Dec 31, 2020      YEAR     
                   LATEST         YEAR-AGO         COMPANY        COMPANY   
                   RESULTS         RESULTS         FORECAST     H1 FORECAST 
  Sales             14.46           9.92                                    
                 (+45.8 pct)     (+10.6 pct)                                
  Operating          3.70           1.93                                    
                 (+91.2 pct)     (+9.4 pct)                                 
  Recurring          3.52           1.79                                    
                 (+97.0 pct)     (+18.1 pct)                                
  Net                2.36           1.33                                    
                 (+76.8 pct)     (+27.1 pct)                                
  EPS             55.31 yen       31.09 yen                                 
  EPS Diluted     55.09 yen       31.05 yen                                 
  Ann Div         50.00 yen       35.00 yen       17.00 yen                 
  -Q2 Div         10.00 yen       10.00 yen        7.00 yen                 
  -Q4 Div         40.00 yen       25.00 yen       10.00 yen                 
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T